Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol

experimental and pharmacological evaluation

Seiji Kobayashi, Yoshiaki Narimatsu, Kenji Ogawa, Subaru Hashimoto, Seishi Nakatsuka, Hiroshi Miura, Hirokuni Ohzono, Wei Jei Ka, Kunio Ido, Kyoichi Hiramatsu, Toshiharu Tsuzuki, Masaharu Tsuchiya

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The experimental and pharmacological characteristics of various formulations of an anticancer agent (epirubicin, EPI) and lipiodol were evaluated in vitro and in vivo. Three forms of EPI-lipiodol, i.e., an oil-in-water type of emulsion (O/W type), a water-in-oil type of emulsion (W/O type), and a suspension (S type), were prepared and investigated for their stability. An O/W-type emulsion using a stock solution of Iopamidol as the solvent for EPI was the most stable form in the stationary state in vitro. In 16 patients with malignant liver tumors (14 hepatocellular carcinomas and 2 liver metastases), the three forms of EPI-lipiodol were injected into the proper hepatic artery. The plasma EPI level was monitored periodically and analyzed pharmacokinetically. No significant difference in the pharmacokinetics of EPI was detected among the O/W, W/O, and S types.

Original languageEnglish
JournalCancer Chemotherapy and Pharmacology
Volume31
Issue number1 Supplement
DOIs
Publication statusPublished - 1992 Jan

Fingerprint

Ethiodized Oil
Epirubicin
Pharmacology
Liver
Emulsions
Oils
Iopamidol
Pharmacokinetics
Water
Hepatic Artery
Antineoplastic Agents
Tumors
Hepatocellular Carcinoma
Suspensions
Neoplasm Metastasis
Plasmas
Neoplasms

ASJC Scopus subject areas

  • Pharmacology
  • Oncology
  • Cancer Research

Cite this

Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol : experimental and pharmacological evaluation. / Kobayashi, Seiji; Narimatsu, Yoshiaki; Ogawa, Kenji; Hashimoto, Subaru; Nakatsuka, Seishi; Miura, Hiroshi; Ohzono, Hirokuni; Ka, Wei Jei; Ido, Kunio; Hiramatsu, Kyoichi; Tsuzuki, Toshiharu; Tsuchiya, Masaharu.

In: Cancer Chemotherapy and Pharmacology, Vol. 31, No. 1 Supplement, 01.1992.

Research output: Contribution to journalArticle

Kobayashi, S, Narimatsu, Y, Ogawa, K, Hashimoto, S, Nakatsuka, S, Miura, H, Ohzono, H, Ka, WJ, Ido, K, Hiramatsu, K, Tsuzuki, T & Tsuchiya, M 1992, 'Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol: experimental and pharmacological evaluation', Cancer Chemotherapy and Pharmacology, vol. 31, no. 1 Supplement. https://doi.org/10.1007/BF00687104
Kobayashi, Seiji ; Narimatsu, Yoshiaki ; Ogawa, Kenji ; Hashimoto, Subaru ; Nakatsuka, Seishi ; Miura, Hiroshi ; Ohzono, Hirokuni ; Ka, Wei Jei ; Ido, Kunio ; Hiramatsu, Kyoichi ; Tsuzuki, Toshiharu ; Tsuchiya, Masaharu. / Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol : experimental and pharmacological evaluation. In: Cancer Chemotherapy and Pharmacology. 1992 ; Vol. 31, No. 1 Supplement.
@article{9dc3264c309548c5b1faf1f7f09c1c7a,
title = "Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol: experimental and pharmacological evaluation",
abstract = "The experimental and pharmacological characteristics of various formulations of an anticancer agent (epirubicin, EPI) and lipiodol were evaluated in vitro and in vivo. Three forms of EPI-lipiodol, i.e., an oil-in-water type of emulsion (O/W type), a water-in-oil type of emulsion (W/O type), and a suspension (S type), were prepared and investigated for their stability. An O/W-type emulsion using a stock solution of Iopamidol as the solvent for EPI was the most stable form in the stationary state in vitro. In 16 patients with malignant liver tumors (14 hepatocellular carcinomas and 2 liver metastases), the three forms of EPI-lipiodol were injected into the proper hepatic artery. The plasma EPI level was monitored periodically and analyzed pharmacokinetically. No significant difference in the pharmacokinetics of EPI was detected among the O/W, W/O, and S types.",
author = "Seiji Kobayashi and Yoshiaki Narimatsu and Kenji Ogawa and Subaru Hashimoto and Seishi Nakatsuka and Hiroshi Miura and Hirokuni Ohzono and Ka, {Wei Jei} and Kunio Ido and Kyoichi Hiramatsu and Toshiharu Tsuzuki and Masaharu Tsuchiya",
year = "1992",
month = "1",
doi = "10.1007/BF00687104",
language = "English",
volume = "31",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "1 Supplement",

}

TY - JOUR

T1 - Transcatheter hepatic arterial chemoembolization using epirubicin-lipiodol

T2 - experimental and pharmacological evaluation

AU - Kobayashi, Seiji

AU - Narimatsu, Yoshiaki

AU - Ogawa, Kenji

AU - Hashimoto, Subaru

AU - Nakatsuka, Seishi

AU - Miura, Hiroshi

AU - Ohzono, Hirokuni

AU - Ka, Wei Jei

AU - Ido, Kunio

AU - Hiramatsu, Kyoichi

AU - Tsuzuki, Toshiharu

AU - Tsuchiya, Masaharu

PY - 1992/1

Y1 - 1992/1

N2 - The experimental and pharmacological characteristics of various formulations of an anticancer agent (epirubicin, EPI) and lipiodol were evaluated in vitro and in vivo. Three forms of EPI-lipiodol, i.e., an oil-in-water type of emulsion (O/W type), a water-in-oil type of emulsion (W/O type), and a suspension (S type), were prepared and investigated for their stability. An O/W-type emulsion using a stock solution of Iopamidol as the solvent for EPI was the most stable form in the stationary state in vitro. In 16 patients with malignant liver tumors (14 hepatocellular carcinomas and 2 liver metastases), the three forms of EPI-lipiodol were injected into the proper hepatic artery. The plasma EPI level was monitored periodically and analyzed pharmacokinetically. No significant difference in the pharmacokinetics of EPI was detected among the O/W, W/O, and S types.

AB - The experimental and pharmacological characteristics of various formulations of an anticancer agent (epirubicin, EPI) and lipiodol were evaluated in vitro and in vivo. Three forms of EPI-lipiodol, i.e., an oil-in-water type of emulsion (O/W type), a water-in-oil type of emulsion (W/O type), and a suspension (S type), were prepared and investigated for their stability. An O/W-type emulsion using a stock solution of Iopamidol as the solvent for EPI was the most stable form in the stationary state in vitro. In 16 patients with malignant liver tumors (14 hepatocellular carcinomas and 2 liver metastases), the three forms of EPI-lipiodol were injected into the proper hepatic artery. The plasma EPI level was monitored periodically and analyzed pharmacokinetically. No significant difference in the pharmacokinetics of EPI was detected among the O/W, W/O, and S types.

UR - http://www.scopus.com/inward/record.url?scp=0026564495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026564495&partnerID=8YFLogxK

U2 - 10.1007/BF00687104

DO - 10.1007/BF00687104

M3 - Article

VL - 31

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 1 Supplement

ER -